Your session is about to expire
← Back to Search
Genetic Testing for Parkinson's Disease (PDGENE Trial)
N/A
Waitlist Available
Led By Roy N Alcalay, MD, MS
Research Sponsored by Parkinson's Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test how well a genetic testing program works when offered to people with Parkinson's disease.
Who is the study for?
This trial is for people with a probable diagnosis of Parkinson's Disease who can consent to the study, complete surveys, and are willing to undergo genetic testing. They must understand the language of the informed consent. Those with blood cancers, recent bone marrow transplants or blood transfusions, or atypical parkinsonian disorders cannot participate.
What is being tested?
The trial is offering certified genetic testing for seven specific gene variants linked to Parkinson's Disease as part of clinical care. It aims to evaluate how feasible and satisfying this process is for participants.
What are the potential side effects?
Since this trial involves only genetic testing without any drugs or medical procedures, there are no direct physical side effects expected from participating in this study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Feasibility of genetic testing and counseling
Impact Evaluation
Satisfaction Comparison
Secondary study objectives
Number of participants that enroll in precision medicine trials
Time it takes between first contact to the return of genetic test results
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Site-Based Genetic CounselingActive Control1 Intervention
Participants randomized to this arm will receive genetic counseling for genetic results through the enrolling site.
Group II: Centralized Genetic CounselingActive Control1 Intervention
Participants randomized to this arm will receive genetic counseling for genetic results through a centralized genetic counseling group at Indiana University.
Find a Location
Who is running the clinical trial?
University of Rochester - CHeT/CTCCUNKNOWN
Parkinson's FoundationLead Sponsor
11 Previous Clinical Trials
1,028,902 Total Patients Enrolled
Fulgent LaboratoriesUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can complete study tasks, whether online, in-person, or on paper.I understand the study details and have signed the consent forms.I have been diagnosed with a rare form of Parkinson's disease.I have received a blood transfusion in the last 3 months.I have an active blood cancer like lymphoma or leukemia.I had a bone marrow transplant within the last 5 years.I agree to genetic testing for Parkinson's disease and want to know the results.
Research Study Groups:
This trial has the following groups:- Group 1: Site-Based Genetic Counseling
- Group 2: Centralized Genetic Counseling
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger